Intelligence

Consumer Discretionary

Charlie's Holdings Reports Over $6 Million in Sales at NACS Show

Author:
FAQsIR News Desk
Last Updated:
Reading Time
2 min

#Record Sales Achievement

Charlie's Holdings, Inc. has announced a substantial milestone in its sales performance, securing over $6 million in orders during the National Association of Convenience Stores (NACS) Show held recently in Chicago. Among these orders, a noteworthy cash deposit of $4.4 million was placed for the company's SBX product line, marking the largest single sale in the firm's history.

#Growth in Non-Nicotine Products

The SBX line, which is a non-nicotine product, provides consumers with the flavors and sensations similar to traditional nicotine vaping products while complying with regulations established for nicotine-containing items. This strategic positioning is expected to enhance Charlie's distribution footprint across chain convenience stores, particularly those interested in offering flavored disposable vapes without violating FDA stipulations.

#Impressive Sales Performance

Charlie’s recent sales figures reflect a remarkable increase in market demand; the total of $6 million from the NACS Show surpasses the company’s entire sales for the first quarter of 2025 by three times. Additionally, this figure accounts for approximately 75% of the total sales achieved throughout the entirety of 2024, underscoring the rapid growth trajectory the company is experiencing.

#Future Outlook and Strategic Focus

Looking ahead, Charlie's management is optimistic about achieving their highest revenue quarter in Q4 2025, driven by the momentum from their product lines, including SBX, PACHA, and Pachamama 25K. They recognize the tremendous potential of SBX, especially given user preference over competing brands such as Juul. If SBX can establish a distribution network comparable to Juul's, annual sales could potentially reach hundreds of millions of dollars.

#Key Takeaways

  • Charlie's Holdings secured over $6 million in sales at the NACS Show, including a record-breaking $4.4 million order for SBX.
  • The SBX product line is a non-nicotine offering aimed at consumers looking for flavor without regulatory concerns.
  • This sales achievement is three times higher than Charlie's entire first-quarter sales in 2025.
  • The company is poised for aggressive growth, particularly in Q4 2025, with expectations for increased revenue across its product lines.
  • Management believes capturing a fraction of Juul's retail distribution could significantly boost sales potential.

Original source: Read original article

Frequently Asked Questions

Charlie's Holdings recently reported over $6 million in purchase orders secured at the National Association of Convenience Stores show, including a record-breaking $4.4 million purchase order for their SBX product line.
The SBX product is a non-nicotine offering that allows users to enjoy similar flavours and sensations to traditional nicotine products without the associated regulatory concerns, making it an appealing choice for many consumers.
Charlie's Holdings is on a significant growth trajectory, with revenues from recent sales indicating that Q4 2025 may become their highest-grossing quarter ever, reflecting strong market demand for their product lines.
The company has seen a dramatic increase in its sales, reporting that the recent $6 million in orders is triple what they sold in the entire first quarter of 2025, highlighting a robust demand for their innovation.
Given that SBX is preferred over other brands like Juul, if Charlie's can capture even a fraction of Juul's distribution network, it points to a substantial growth opportunity potentially reaching hundreds of millions in sales.
The company aims to pursue steady and measured growth across its brands, with particular emphasis on further expanding the SBX line, indicating a strategic commitment to maximizing its emerging market presence.
Investors should consider the potential impacts of the FDA's regulatory landscape on nicotine products, including the need for PMTA authorisations, as these could influence future sales and product acceptance.
Management believes that with strong early performance and expanding retail partnerships, Charlie's future sales may significantly increase, underlining a positive outlook for the company's growth in the premium vapor products market.